What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News La Fundació ”la Caixa” atorga 1,5 milions d’euros a investigacions socials d'excel·lència L’entitat ha finançat un total de 15 projectes. News New Vall d’Hebron research building work begins The building will have an area of 16,792 m2 dedicated to research and will house the latest technology in the field of advanced therapies. News Vall d’Hebron researchers publish a review on the influence of radiotherapy and cancer surgery on the immune system The work, published in Frontiers in Oncology, emphasizes the role of the tumor microenvironment in response to treatments. News Vall d’Hebron will study how virtual reality can improve the treatment of obesity The researchers will develop a virtual reality system that will allow obese patients to be aware of their body, overcome stigma, increase their self-esteem and help them cope with the lifestyle changes necessary to start losing weight. News Two researchers at Vall d’Hebron awarded at the 2020 Multiple Sclerosis Solidarity Awards Dr. Manuel Comabella and Dr. Sunny Malhotra have been recognized by Fundación Merck Salud for their research on prognostic factors for multiple sclerosis. News Vall d'Hebron suggests that the immune system through a cytotoxic attack of T lymphocytes would cause Parkinson's disease This study may become a first step in definitively determining the cause of Parkinson’s disease and in establishing new therapeutic targets to stop or even prevent the disease. News Vall d'Hebron begins clinical trial of Janssen's Covid-19 vaccine This week Vall d'Hebron has started recruiting volunteers to participate in the phase III clinical trial of the Covid-19 vaccine from Janssen Pharmaceuticals (Johnson & Johnson). News Vall d’Hebron designs boxes with humanizing illustrations to cover the serums of pediatric patients The Superbox initiative aims to provide an innovative tool for pediatric patients so that they can live the medication experience more positively and increase their well-being. News Vall d’Hebron includes the world’s first patient in Pfizer’s Phase 3 gene therapy clinical trial for Duchenne muscular dystrophy Vall d'Hebron became the first center in the world to include a patient (a 5-year-old boy) in the phase 3 gene therapy clinical trial for Duchenne muscular dystrophy. News One in four patients admitted to the ICU with COVID-19 suffers a thrombosis, which in many cases is asymptomatic The study, carried out with 230 patients at the ICUs of the Vall d'Hebron and Germans Trias i Pujol University Hospitals, is the world's largest published series of patients with COVID-19 and thrombosis in the ICU. Pagination Previous page ‹‹ Page 51 Next page ››